Skip to main content Accessibility help
×
Home

Psyche at the end of life: Psychiatric symptoms are prevalent in patients admitted to a palliative care unit

  • Eva K. Masel (a1), Anna S. Berghoff (a2), Aleksandra Mladen (a1), Sophie Schur (a1), Bruno Maehr (a1), Magdalena Kirchhoff (a1), Ralph Simanek (a1), Martin Bauer (a3), Herbert H. Watzke (a1) and Michaela Amering (a4)...

Abstract

Objective:

Our aim was to evaluate the frequency and treatment of psychiatric symptoms in patients at palliative care units (PCUs).

Method:

Patients admitted to one of five participating PCUs in Austria were included. The short version of the Patient Health Questionnaire (PHQ–D) was used to evaluate their mental health status. Pain intensity was rated on a numeric rating scale (NRS) from 0 to 10 by patients and physicians. Patients with a previously diagnosed psychiatric disorder were compared to those without or with newly diagnosed psychiatric symptoms, based on PHQ–D results. Pain and psychopharmacological medication were assessed. Opioid doses were converted into oral morphine equivalents (OMEs).

Results:

Some 68 patients were included. Previously undetected psychiatric symptoms were identified in 38% (26 of 68), preexisting psychiatric comorbidities were evident in 25% (17), and no psychiatric symptoms were observed in 37% (25). Patients with a preexisting psychiatric comorbidity received antidepressants and benzodiazepines significantly more often than patients without or with previously undetected psychiatric symptoms (p < 0.001). Patient and physician median NRS ratings of pain intensity correlated significantly (p = 0.001). Median NRS rating showed no significant difference between patients with preexisting, previously undetected, or without psychiatric symptoms. OMEs did not differ significantly between preexisting, without, or previously undetected psychiatric symptoms. Patients with undetected and preexisting psychiatric comorbidities had a greater impairment in their activities of daily living than patients without psychiatric symptoms (p = 0.003).

Significance of Results:

Undetected psychiatric comorbidities are common in patients receiving palliative care. Screening for psychiatric symptoms should be integrated into standard palliative care to optimize treatment and reduce the psychosocial burden of the disease.

Copyright

Corresponding author

Address correspondence and reprint requests to: Eva K. Masel, Division of Palliative Care, Department of Internal Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. E-mail: eva.masel@meduniwien.ac.at.

References

Hide All
Anderson, R., Saiers, J.H., Abram, S., et al. (2001). Accuracy in equianalgesic dosing: Conversion dilemmas. Journal of Pain and Symptom Management, 21(5), 397406.
Bender, R. & Lange, S. (2001). Adjusting for multiple testing: When and how? Journal of Clinical Epidemiology, 54(4), 343349.
Breitbart, W. (2004). Psycho-oncology and palliative care: Opportunity for integration. Palliative & Supportive Care, 2(2), 113114.
Breitbart, W. (2006). The goals of palliative care: Beyond symptom control. Palliative & Supportive Care, 4(1), 12.
Breitbart, W., Chandler, S., Eagel, B., et al. (2000). An alternative algorithm for dosing transdermal fentanyl for cancer-related pain. Oncology, 14(5), 695705.
Brown, L.F., Kroenke, K., Theobald, D.E., et al. (2010). The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain. Psycho-Oncology, 19(7), 734741.
Carlson, L.E., Angen, M., Cullum, J., et al. (2004). High levels of untreated distress and fatigue in cancer patients. British Journal of Cancer, 90(12), 22972304.
Ciaramella, A., Grosso, S., Poli, P., et al. (2004). When pain is not fully explained by organic lesion: A psychiatric perspective on chronic pain patients. European Journal of Pain, 8(1), 1322.
Cipriani, A., La Ferla, T., Furukawa, T.A., et al. (2010). Sertraline versus other antidepressive agents for depression. The Cochrane Database of Systematic Reviews, 14(4). doi: 10.1002/14651858.CD006117.pub2.
Cleeland, C.S., Gonin, R., Hatfield, A.K., et al. (1994). Pain and its treatment in outpatients with metastatic cancer. The New England Journal of Medicine, 330(9), 592596.
Fasse, L., Flahault, C., Bredart, A., et al. (2015). Describing and understanding depression in spouses of cancer patients in palliative phase. Psycho-Oncology, 24(10), doi: 10.1002/pon.3777 [Epub ahead of print].
Furukawa, T.A., McGuire, H. & Barbui, C. (2002). Meta-analysis of effects and side effects of low-dosage tricyclic antidepressants in depression: Systematic review. BMJ, 325(7371), 991.
Gibson, C.A., Lichtenthal, W., Berg, A., et al. (2006). Psychological issues in palliative care. Anesthesiology Clinics, 24(1), 6180.
Grande, G.E. & Todd, C.J. (2000). Why are trials in palliative care so difficult? Palliative Medicine, 14(1), 6974.
Guidi, J., Fava, G.A., Bech, P., et al. (2011). The Clinical Interview for Depression: A comprehensive review of studies and clinimetric properties. Psychotherapy and Psychosomatics, 80(1), 1027.
Iliffe, S., Kharicha, K., Carmaciu, C., et al. (2009). The relationship between pain intensity and severity and depression in older people: Exploratory study. BMC Family Practice, 10(54), 14712296.
Irwin, S.A. & Ferris, F.D. (2008). The opportunity for psychiatry in palliative care. Canadian Journal of Psychiatry, 53(11), 713724.
Jaiswal, R., Alici, Y. & Breitbart, W. (2014). A comprehensive review of palliative care in patients with cancer. International Review of Psychiatry, 26(1), 87101.
Kapoor, S. (2013). Additional advantages of mirtazapine therapy in cancer patients: Beyond its role as an antidepressant. Journal of Pain and Symptom Management, 45(3), e3e4. doi: 10.1016/j.jpainsymman.2012.12.001 [Epub ahead of print January 29].
Kroenke, K., Spitzer, R.L. & Williams, J.B. (2001). The PHQ–9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606613.
Lemogne, C., Consoli, S.M., Melchior, M., et al. (2013). Depression and the risk of cancer: A 15-year follow-up study of the GAZEL cohort. American Journal of Epidemiology, 178(12), 17121720.
Lin, C.C., Lai, Y.L. & Ward, S.E. (2003). Effect of cancer pain on performance status, mood states, and level of hope among Taiwanese cancer patients. Journal of Pain and Symptom Management, 25(1), 2937.
Lloyd-Williams, M. (2000). Difficulties in diagnosing and treating depression in the terminally ill cancer patient. Postgraduate Medical Journal, 76(899), 555558.
Lloyd-Williams, M. (2001). Screening for depression in palliative care patients: A review. European Journal of Cancer Care, 10(1), 3135.
Lo, C., Zimmermann, C., Rydall, A., et al. (2010). Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. Journal of Clinical Oncology, 28(18), 30843089.
Lo, C., Calzavara, A., Kurdyak, P., et al. (2013). Depression and use of health care services in patients with advanced cancer. Canadian Family Physician, 59(3), e168174.
Miguel, C. & Albuquerque, E. (2011). Drug interaction in psycho-oncology: Antidepressants and antineoplastics. Pharmacology, 88(5–6), 333339.
Nekolaichuk, C.L., Bruera, E., Spachynski, K., et al. (1999). A comparison of patient and proxy symptom assessments in advanced cancer patients. Palliative Medicine, 13(4), 311323.
Nissim, R., Freeman, E., Lo, C., et al. (2012). Managing Cancer and Living Meaningfully (CALM): A qualitative study of a brief individual psychotherapy for individuals with advanced cancer. Palliative Medicine, 26(5), 713721.
Onitilo, A.A., Nietert, P.J. & Egede, L.E. (2006). Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. General Hospital Psychiatry, 28(5), 396402.
Pereira, J., Lawlor, P., Vigano, A., et al. (2001). Equianalgesic dose ratios for opioids: A critical review and proposals for long-term dosing. Journal of Pain and Symptom Management, 22(2), 672687.
Pessin, H., Galietta, M., Nelson, C.J., et al. (2008). Burden and benefit of psychosocial research at the end of life. Journal of Palliative Medicine, 11(4), 627632.
Rome, R.B., Luminais, H.H., Bourgeois, D.A., et al. (2011). The role of palliative care at the end of life. The Ochsner Journal, 11(4), 348352.
Satin, J.R. (2010). Review: Depression is associated with increased cancer mortality. Evidence-Based Mental Health, 13(2), 41.
Scherrer, J.F., Salas, J., Lustman, P.J., et al. (2015). Change in opioid dose and change in depression in a longitudinal primary care patient cohort. Pain, 156(2), 348355.
Singer, S., Danker, H., Briest, S., et al. (2014). Effect of a structured psycho-oncological screening and treatment model on mental health in cancer patients (STEPPED CARE): Study protocol for a cluster randomized controlled trial. Trials, 15, 482. doi: 10.1186/1745-6215-15-482.
Spitzer, R.L., Williams, J.B., Kroenke, K., et al. (1994). Utility of a new procedure for diagnosing mental disorders in primary care: The PRIME–MD 1000 study. The Journal of the American Medical Association, 272(22), 17491756.
Spitzer, R.L., Kroenke, K. & Williams, J.B. (1999). Validation and utility of a self-report version of PRIME–MD: The PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. The Journal of the American Medical Association, 282(18), 17371744.
Theobald, D.E., Kirsh, K.L., Holtsclaw, E., et al. (2002). An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. Journal of Pain and Symptom Management, 23(5), 442447.
Vignaroli, E., Pace, E.A., Willey, J., et al. (2006). The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. Journal of Palliative Medicine, 9(2), 296303.
Walker, J., Hansen, C.H., Martin, P., et al. (2014). Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): A multicentre randomised controlled trial in patients with lung cancer. The Lancet. Oncology, 15(10), 11681176.
Wancata, J., Benda, N., Meise, U., et al. (1998). Use of psychotropic drugs in gynecological, surgical, and medical wards of general hospitals. International Journal of Psychiatry in Medicine, 28(3), 303314.
Whooley, M.A., Avins, A.L., Miranda, J., et al. (1997). Case-finding instruments for depression: Two questions are as good as many. Journal of General Internal Medicine, 12(7), 439445.
Workman, E.A., Hubbard, J.R. & Felker, B.L. (2002). Comorbid psychiatric disorders and predictors of pain management program success in patients with chronic pain. The Primary Companion to the Journal of Clinical Psychiatry, 4(4), 137140.
Zimmerman, M. & Mattia, J.I. (1999). Psychiatric diagnosis in clinical practice: Is comorbidity being missed? Comprehensive Psychiatry, 40(3), 182191.

Keywords

Psyche at the end of life: Psychiatric symptoms are prevalent in patients admitted to a palliative care unit

  • Eva K. Masel (a1), Anna S. Berghoff (a2), Aleksandra Mladen (a1), Sophie Schur (a1), Bruno Maehr (a1), Magdalena Kirchhoff (a1), Ralph Simanek (a1), Martin Bauer (a3), Herbert H. Watzke (a1) and Michaela Amering (a4)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed